XML 85 R72.htm IDEA: XBRL DOCUMENT v3.21.1
Investments in and Advances to Joint Ventures - Summary of Financial Information for Unconsolidated Joint Ventures (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Schedule Of Equity Method Investments [Line Items]      
Current assets $ 1,802,207   $ 1,843,130
Total assets 3,865,001   3,937,704
Current liabilities 1,110,667   1,187,409
Total liabilities 2,024,559   2,076,287
Total joint venture equity 1,796,799   1,813,772
Investments in and advances to unconsolidated joint ventures 76,017   68,975
Revenue 874,697 $ 970,993  
Costs 669,082 769,632  
Net income attributable to Parsons Corporation 9,039 12,973  
Equity in earnings of unconsolidated joint ventures 7,530 6,114  
Unconsolidated Joint Ventures      
Schedule Of Equity Method Investments [Line Items]      
Current assets 740,595   774,646
Noncurrent assets 580,224   585,802
Total assets 1,320,819   1,360,448
Current liabilities 673,872   703,287
Noncurrent liabilities 528,168   517,697
Total liabilities 1,202,040   1,220,984
Total joint venture equity 118,779   139,464
Investments in and advances to unconsolidated joint ventures 76,017   $ 68,975
Revenue 236,517 238,188  
Costs 210,847 223,686  
Net income attributable to Parsons Corporation 25,670 14,502  
Equity in earnings of unconsolidated joint ventures $ 7,530 $ 6,114